Vivity Outcomes in Patients With Early Stage Glaucoma (VIVA)

Vance Thompson Vision

Status: Completed

Conditions: Cataract; Glaucoma; Presbyopia

Treatments: Procedure: Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL

Study type: Observational

Funder types: Other

Identifiers

NCT04670575

VIVA

Details and patient eligibility

About

The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens (IOL).

Enrollment: 27 patients

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients at least age 45 years of age undergoing uncomplicated cataract surgery with optional concomitant minimally invasive glaucoma surgery (MIGS)
2. Subjects with documented diagnosis of pre-perimetric glaucoma
3. Calculated lens power within Vivity/Vivity toric range
4. Willing and able to comprehend informed consent and complete 4-6 month post-op visit
5. Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion

Exclusion criteria

1. Ocular comorbidity, other than pre-perimetric glaucoma, that could reduce the potential postoperative BCDVA
2. Previous ocular surgery including refractive surgery
3. Subjects who are pregnant or plan to become pregnant during the course of the study.

Trial design

27 participants in 1 patient group

Vivity

Description:

Patients implanted with Vivity or Vivity Toric intraocular lens at the time of cataract surgery.

Treatment:

Procedure: Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL